Discover trends, market shifts, and competitive outlooks for the crohn’s disease treatment industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Crohn’s Disease Treatment Market In 2029?

There has been considerable growth in the market size for Crohn’s disease treatment in the recent past. The market, worth $12.45 billion in 2024, is projected to escalate to $13.23 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.2%. The growth witnessed during the historical period is due to factors such as the rise in disease prevalence, advancements in diagnosis methods, adoption of biological therapies, heightened patient awareness and education, and progress in clinical research and development.

Robust growth is forecasted for the Crohn’s disease treatment market in the upcoming years, with projections pointing to a valuation of “$17.67 billion by 2029. This represents a compound annual growth rate (CAGR) of 7.5%. The anticipated growth through the forecast period can be traced back to factors such as advancements in personalized medicine, an expanding biologics market, implementation of updated treatment guidelines, higher healthcare expenditures, and synergized research endeavors. Predominantly, the forecast period will witness trends like the utilization of telemedicine for patient monitoring, exploration of immune modulation tactics, the rise of patient-centered care frameworks, and the seamless integration of digital health solutions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10852&type=smp

What are the Fundamental Drivers and Innovations Shaping the Crohn’s Disease Treatment Market?

The growing occurrence of inflammatory bowel disorders is anticipated to drive the expansion of the Crohn’s disease treatment market. These disorders are a series of chronic conditions relating to inflammation of the gastrointestinal tract. They could potentially cause inflammation and damage to any part of the digestive system, from mouth to anus. Crohn’s disease treatment aims at minimizing intestinal inflammation, preventing symptom flare-ups, and maintaining remission. For example, the National Center for Biotechnology Information, a US government entity, reported in September 2023 the escalating prevalence of Crohn’s disease and ulcerative colitis. Inflammatory bowel disease is anticipated to reach 825 cases per 100,000 people in 2023—410 for Crohn’s disease and 414 for ulcerative colitis and IBD-u. Consequently, this increasing prevalence of these disorders is driving the growth of the Crohn’s disease treatment market.

How Is the Crohn’s Disease Treatment Market Segmented?

The crohn’s disease treatment market covered in this report is segmented –

1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Application: Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine Post-Operative Pain, Cancer Pain, Other Applications

Subsegments:

1) By Antibiotics: Metronidazole, Ciprofloxacin, Other Antibiotics

2) By Amino Salicylates: Mesalamine, Sulfasalazine, Other Amino Salicylates

3) By Corticosteroids: Prednisone, Budesonide, Other Corticosteroids

4) By Immunomodulators: Azathioprine, Methotrexate, Mercaptopurine

5) By Other Drug Types: Biologics, Small Molecules, Other Treatments

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10852&type=smp

Which Regions Are Driving the Next Phase of the Crohn’s Disease Treatment Market Growth?

North America was the largest region in the global Crohn’s disease treatment market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the Crohn’s disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Trends Are Shaping the Future of the Crohn’s Disease Treatment Market?

Leading firms in the Crohn’s disease treatment market are harnessing innovative methodologies to develop and approve new medications such as biosimilar ustekinumab. This allows for a more efficacious and accessible treatment alternative, which can significantly enhance patient prognosis and quality of life. Biosimilar ustekinumab is a biologic drug that is highly similar to the original ustekinumab (a monoclonal antibody) utilised in the treatment of autoimmune conditions. A case in point is Sandoz International GmbH, a pharmaceutical company based in Switzerland, that in July 2024, introduced Pyzchiva (ustekinumab) in Europe. This marked the first instance of a ustekinumab biosimilar being available in all strengths, including a 130 mg vial, specifically for Crohn’s disease. Pyzchiva is set for use by adults and children over six for conditions such as plaque psoriasis, psoriatic arthritis, and Crohn’s disease. This is a step forward in broadening Sandoz’s immunology offering and paves the way for improved access to cost-effective treatments for chronic inflammatory diseases.

View the full report here:

https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report

How Is the Crohn’s Disease Treatment Market Defined and What Are Its Core Parameters?

Crohn’s disease treatment refers to medical intervention and therapies used to manage Crohn’s disease, a chronic pathological condition of the gastrointestinal tract. The treatment aims are to reduce inflammation in the intestines, prevent flare-ups of symptoms, and maintain recovery.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10852

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model